TY - JOUR
T1 - Bifidobacterium-driven immunoglobulin A production in pediatric patients with IgA deficiency and recurrent respiratory tract infections
AU - Koenen, Mischa H
AU - de Jonge, Marien I
AU - Hermsen, Meyke
AU - van Weelden, Geert H
AU - Olde Olthof, Sanne
AU - van der Gaast-de Jongh, Christa E
AU - van Opzeeland, Fred
AU - de Kluijs-Bender, Charlene
AU - van Selm, Saskia
AU - van der Vries, Erhard
AU - Bogaert, Debby
AU - Boes, Marianne
AU - de Zoete, Marcel R
AU - Verhagen, Lilly M
N1 - MJ, MdZ and LV contributed to the concept and design of the here presented study. MK and LV were responsible for patient recruitment, sample and data collection, storage, and analysis of clinical data. FvO, CdKB, SvS performed the mouse handling and associated laboratory experiments. Immunohistochemical coloring was performed by GvW and deep learning driven analysis of these tissues was conducted by MH. Laboratory work for the microbiota analysis and downstream handling of data was conducted by MK and MdZ. Laboratory work for the Bifidobacterium qPCR was performed by SOO and CvdGdJ. MK, MJ, EvdV, DB, MB, MdZ and LV contributed toward data interpretation and to writing the manuscript. All authors confirm that they read the manuscript and agree with the decision to submit for publication.
PY - 2026/5/14
Y1 - 2026/5/14
N2 - BACKGROUND: Immunoglobulin A (IgA) deficiency is the most common primary antibody deficiency and contributes to recurrent respiratory tract infections (rRTIs) in children, with prevalence rates in this group ranging from 1:4 to 1:65. Previous studies in healthy humans and animals suggest that the gut microbiota significantly influences IgA production. We investigated the role of the gut microbiota in IgA deficiency and its potential in promoting IgA induction in children with rRTIs.RESULTS: Children under 7 years of age with rRTIs were enrolled in a prospective cohort study. Serum and feces were collected for IgA level measurement using ELISA and to determine the composition of the intestinal microbiota by 16S rRNA sequencing. We included 82 children with rRTIs, 38% of whom were IgA deficient. The microbiota composition of IgA deficient children differed from that of symptomatic non-IgA deficient children (PERMANOVA R
2 2.4%, p = 0.02). Feces from a subgroup of children with and without IgA deficiency were used to inoculate germ-free mice. At baseline and after 3, 8, 12, and 16 weeks, serum and fecal samples were collected from the mice for measurement of IgA levels and microbiota composition. We also collected B-cells from lung and colon tissues for immunohistochemistry. The introduction of microbiota in germ-free mice was related to a strong induction of serum and fecal IgA levels and associated with the abundance of specific bacterial genera, including several Lachnospiraceae species. Two community clusters were associated with fecal IgA induction, one of which was a Bifidobacterium cluster, consisting of eight bacterial genera. This Bifidobacterium cluster was also associated with higher serum and lung IgA levels and increased lung B-cell density in mice. Furthermore, in children with rRTIs, Bifidobacterium abundance was negatively associated with the severity of RTI symptoms.
CONCLUSIONS: This study shows that children with IgA deficiency and rRTIs harbour a distinctly altered intestinal microbiota. Using fecal transfers from pediatric donors into germ-free mice, we demonstrate robust induction of IgA across mucosal sites. Notably, a Bifidobacterium-dominated community cluster was linked to stronger IgA responses in stool, serum, and lung, highlighting a microbiota-mucosal immunity axis with translational potential. Video Abstract.
AB - BACKGROUND: Immunoglobulin A (IgA) deficiency is the most common primary antibody deficiency and contributes to recurrent respiratory tract infections (rRTIs) in children, with prevalence rates in this group ranging from 1:4 to 1:65. Previous studies in healthy humans and animals suggest that the gut microbiota significantly influences IgA production. We investigated the role of the gut microbiota in IgA deficiency and its potential in promoting IgA induction in children with rRTIs.RESULTS: Children under 7 years of age with rRTIs were enrolled in a prospective cohort study. Serum and feces were collected for IgA level measurement using ELISA and to determine the composition of the intestinal microbiota by 16S rRNA sequencing. We included 82 children with rRTIs, 38% of whom were IgA deficient. The microbiota composition of IgA deficient children differed from that of symptomatic non-IgA deficient children (PERMANOVA R
2 2.4%, p = 0.02). Feces from a subgroup of children with and without IgA deficiency were used to inoculate germ-free mice. At baseline and after 3, 8, 12, and 16 weeks, serum and fecal samples were collected from the mice for measurement of IgA levels and microbiota composition. We also collected B-cells from lung and colon tissues for immunohistochemistry. The introduction of microbiota in germ-free mice was related to a strong induction of serum and fecal IgA levels and associated with the abundance of specific bacterial genera, including several Lachnospiraceae species. Two community clusters were associated with fecal IgA induction, one of which was a Bifidobacterium cluster, consisting of eight bacterial genera. This Bifidobacterium cluster was also associated with higher serum and lung IgA levels and increased lung B-cell density in mice. Furthermore, in children with rRTIs, Bifidobacterium abundance was negatively associated with the severity of RTI symptoms.
CONCLUSIONS: This study shows that children with IgA deficiency and rRTIs harbour a distinctly altered intestinal microbiota. Using fecal transfers from pediatric donors into germ-free mice, we demonstrate robust induction of IgA across mucosal sites. Notably, a Bifidobacterium-dominated community cluster was linked to stronger IgA responses in stool, serum, and lung, highlighting a microbiota-mucosal immunity axis with translational potential. Video Abstract.
KW - Humans
KW - IgA Deficiency/microbiology
KW - Respiratory Tract Infections/microbiology
KW - Animals
KW - Bifidobacterium/genetics
KW - Immunoglobulin A/blood
KW - Child
KW - Male
KW - Mice
KW - Female
KW - Child, Preschool
KW - Feces/microbiology
KW - RNA, Ribosomal, 16S/genetics
KW - Prospective Studies
KW - Gastrointestinal Microbiome
KW - Infant
KW - Recurrence
KW - B-Lymphocytes/immunology
KW - Lung/immunology
U2 - 10.1186/s40168-026-02382-0
DO - 10.1186/s40168-026-02382-0
M3 - Article
C2 - 42129858
SN - 2049-2618
VL - 14
JO - Microbiome
JF - Microbiome
M1 - 137
ER -